Liver disease

Resources (which contain promotional information) provided by Norgine.
View TARGAXAN ® (rifaximin-α) prescribing and adverse events reporting information
UK-HEP-XIF-2100027 Date of preparation: October 2021
  • Best practice in hepatic encephalopathy

  • Consensus statement: identification and management of hepatic encephalopathy

Educational resources

Decompensated cirrhosis animation image

Animation on the decompensated cirrhosis care bundle—the first 24 hours

Commissioned by Norgine Pharmaceuticals Limited

This animation has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines in Practice.
UKE-COR-NP-2100080  Date of preparation: October 2021